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IRENE’s mission is to improve the health and well-being 
of Iowans through collaboration in practice-based  
research on questions important to primary care  
physicians and their patients.  IRENE’s purpose is to 
create and foster a network of research collaboration 
between the academic medical center and primary care 
physicians throughout the state of Iowa with a particular 
focus on improving rural health. 
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CONGRATULATIONS To Dr. Barcey Levy!!! 
She was just awarded a National Institutes of Health Recovery Act grant entitled, 
“Enhancing Community-Based Cancer Control in Iowa.” The 3-year award will help 
support the infrastructure to build a partnership among the citizens of Iowa, represented 
by the Iowa Cancer Consortium (an organization of professionals and lay people 
dedicated to reducing the burden of cancer in Iowa), the Iowa Research Network (a 
primary care practice-based research network), and the University of Iowa Holden 
Comprehensive Cancer Center. This partnership will focus initially on understanding and 
addressing the disparities in the burden of colorectal cancer in Iowa.  (See pages 4 & 5) 
Update on the Management of Skin and Soft Tissue Infections by Primary Care 
Clinicians in the Era of Community-Acquired Methicillin Resistant 
Staphylococcus Aureus: An Iowa Research Network Study 
Since most CA-MRSA infections are 
managed initially 
on an outpatient 
basis, it is critical 
that primary care 
clinicians 
recognize and 
treat appropriately 
patients suspected of having such 
infections. The purpose of this study 
was to see if using a “best practices” 
intervention for managing skin 
infections made any difference in the 
management of skin infections, that is 
to determine if there was a difference 
in the management of patients 
presenting with skin and soft 
tissue infections in primary 
care settings before and after 
an educational focus group 
meeting and recommendation 
of use of a skin and soft tissue 
infection algorithm. 
This was a time series design study 
that collected data on the same skin 
and soft tissue infection variables for 
6-12 months prior to the intervention 
and 6-12 months after the 
intervention. Institutional review 
board approval was received for 
retrospective chart review, focus 
group meetings, and prospective 
subject recruitment. Informed consent 
for the prospective component was 
obtained from individual patients by 
the site coordinator who had received 
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Update on the Management of Skin and Soft Tissue Infections (continued from page 1) 
The following offices participated in the study:  
A study team investigator and research assistant visited 
each primary care office for a 
focus group discussion of 
management of skin and soft 
tissue infections, as well as 
review of the CDC guidelines. 
A total of 79 clinicians 
(nurses, nurse practitioners, 
physicians, physician assistants, family practice residents, 
pharmacists) participated. The focus group discussions 
lasted about 50 minutes. During this time, the purpose of 
the study was explained and conversations regarding the 
management of skin and soft tissue infections were recorded and transcribed. The research team provided 
information about the CDC algorithm and the Up-To-Date algorithms for skin and soft tissue infection 
management. 
 
Data analyses included pre- and post- intervention descriptive statistics and comparisons (chi-square for 
proportions and t-tests for continuous data). Two hundred and sixteen (89%) retrospective forms and 118 (95%) 
prospective usable forms were submitted. Mean age for the 334 subjects was 41 years and 47% were male.  
Demographic characteristics were not significantly different by group except for insurance coverage, where 
more prospective subjects had private insurance and fewer had no insurance 
coverage. 
 
Presenting characteristics of the patients were similar for site of infection, 
temperature, duration days of infection prior to being seen, number of risk factors, 
diabetes, being hospitalized, and having allergies to antibiotics. A difference was 
noted in the wound type, with more abscesses in the retrospective and more 
combined abscess and cellulitis wounds in the prospective. Treatment for the infections was similar between 
groups with respect to incision and drainage, culturing the wound, packing the wound, and providing wound care 
instructions. Prescribing antibiotics that covered MRSA at the initial visit and overall during all visits significantly 
increased after the intervention. Prescribing any antibiotic at the first visit also trended towards being significant 
after the intervention. Prescribing a second antibiotic at the initial visit also increased 
significantly after the intervention. The number of antibiotics prescribed before and 
after the intervention did not change. A trend towards scheduling follow-up visits was 
noticed after the intervention. 
 
To determine predictors for whether antibiotic that covered MRSA was prescribed at 
the initial visit or any time during the resolution of the infection, modeling was done.  At 
the initial office visit, an antibiotic covering MRSA was more likely to be prescribed for those in the prospective 
group vs. the retrospective group, if they had an abscess or abscess & cellulitis rather than cellulitis alone, had a 
Family Medicine Associates, Guttenberg, IA  
Genesis Family Medicine, Davenport and Blue Grass, IA  
Medical Associates, LeMars, IA  
Regional Family Health, Manchester, IA  
The Country Doctor, Bloomfield, IA  
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UIHC CMS Sigourney Clinic, Sigourney, IA  
UIHC Family Medicine Clinic, Iowa City, IA  
Urbandale Family Physician, Urbandale, IA  
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 Initial Antibiotic Covered MRSA 
N = 308  
Antibiotics Covered MRSA at Any Time 
N = 313  
 Odds Ratio (CI)  Odds Ratio (CI)  
Prospective group (vs. cellulitis alone) 2.668 (1.54, 4.62)  2.70 (1.77, 4.32)  
Abscess or Abscess & Cellulitis  2.810 (1.62, 4.86)  2.61 (1.63, 4.18)  
Culture Sent  3.03 (1.72, 5.34)  2.54 (1.61, 3.98)  
Had <2 Antibiotics overall (vs. > 2 Antibiotics) 7.67 (2.19, 26.88)   
Patient not hospitalized (vs. hospitalized) 10.55 (1.35, 82.60)   
Age ≥20 and <65 years  1.68 (1.17, 2.57)  
The purpose of this project was to test office reminder systems of gradually increasing intensity to ensure that the 
patient is educated about CRC screening and receives a physician recommendation for screening. Sixteen 
IRENE offices are participating. From those offices, 8,372 potential subjects were invited to participate and 2,007 
returned a baseline survey. From the answers on the baseline survey, we determined 942 were ineligible to 
participate as they self reported already been screened for colon cancer. Of the remainder who were eligible to 
participate in the study, 743 enrolled (signed the informed consent).  Significant differences in the baseline 
questionnaire answers were found.  
See the table below. 
American Cancer Society Colon Cancer Screening Project Update 
abscess or abscess & cellulitis rather than cellulitis, had a culture sent, and were in the age group older than 20 
and younger than 65 years (See Table below). 
Update on the Management of Skin and Soft Tissue Infections (continued from page 2) 
  
Eligible 
(Due for Screening) 
N = 743 
N (%) or Mean (S.D.) 
Ineligible 
(Already Screened) 
N = 942 
N (%) or Mean (S.D.) p-value 
Demographics and History of Colon Cancer 
Age 61 (6.95) 63 (7.06) < 0.0001 
Male 358 (48) 429 (55) 0.258 
Personal history colon cancer 5 (14) 31 (86) 0.0002 
Immediate family member with colon cancer 78 (11) 176 (19) < 0.0001 
Distant relative with colon cancer 83 (11) 172 (18) < 0.0001 
Personal history ulcerative colitis or Crohn’s Disease 6 (1) 32 (3) 0.0004 
 
Physician/Nurse CRC Recommendation    
Doctor or nurse has discussed test for colon cancer 461 (63) 840 (92) < 0.0001 
Doctor has discussed CRC screening 330 (45) 718 (69) < 0.0001 
Doctor recommended CRC screening 
   Age of first recommendation 
   Age of most recent recommendation 
373 (51) 
53 (7.39) 
58 (7.10) 
788 (85) 
53 (9.09) 
60 (7.10) 
< 0.0001 
0.232 
< 0.0001 
Doctor recommended CRC screening because of symptoms 
   Age of first recommendation 
   Age of most recent recommendation 
57 (8) 
51 (10.17) 
57 (9.18) 
< 0.0001 
 0.027 
0.030 
274 (30) 
54 (9.90) 
60 (8.18) 
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In 2001, the Iowa Legislature commissioned a detailed study of the impact of 
cancer on the state. Their report, The Face of Cancer in Iowa, led to the 
formation of the Iowa Consortium for Comprehensive Cancer Control, now 
known as the Iowa Cancer Consortium (ICC). As an organization built on the 
strength of collaboration, the ICC is made up of more than 300 individuals and 
150 organizations, including researchers, legislators, insurance companies, 
health care providers, faith-based organizations, hospice organizations, 
pharmaceutical companies, cancer centers, cancer survivors, public health 
agencies, schools, and a variety of others interested in cancer control. 
The ICC has created and is driven by a comprehensive, statewide cancer plan 
to address critical cancer problems in Iowa, Reducing the Burden of Cancer in 
Iowa. The goals of the plan include:  
 Whenever possible, prevent cancer from occurring. 
 When cancer does occur, find it in its earliest stages. 
 When cancer is found, treat it with the most appropriate therapy. 
 Assure that the quality of life for every cancer patient is the best it can be. 
 Move research findings more quickly into actual practice. 
The infrastructure built as part of this program 
will eventually be applied to community-based 
programs and research that addresses other 
common cancers and life-style issues relating to 
cancer burden (such as tobacco cessation, 
obesity, lack of physical activity, and poor 
dietary practices). 
One of the main goals of the grant will be to 
increase the number of family physician 
practices actively involved in cancer control 
research. Through the grant, we will provide 
support for a total of 50 practices to partner with 
us in this effort. Part of this will include 
information technology support for a computer to 
be placed in your practice that would be used for 
cancer control efforts in your practice (creating 
patient registries), providing learning sessions about cancer control issues, and for your practice to be able to 
meet with and communicate with grant staff at the University using Skype or another form of telecommunication. 
Practices will be brought on in a sequential manner, 12 in year 1, 25 in year 2, and 13 in year 3. 
If you are interested in learning more about this project, please fax back the enclosed form (page 5) 
Enhancing Community-Based Cancer Control in Iowa  
IOWA CANCER CONSORTIUM 
 We have openings for 5 regional Community Assistants to help with this 
project.  We need energetic individuals who are good at organizing 
and collaborating with others. Compensation provided at $10,000 per 
year, working on a part-time basis.   
Position Overview 
The Community Assistant will be the point-person for the facilitation and 
implementation of community-based partnerships in conjunction with 
the University of Iowa and the Iowa Cancer Consortium.  This person 
will provide administrative support and leadership to the Community 
Advisory Board and will be involved with members, organizations, and 
activities of the partnership, bringing together all components to ensure 
the success of the partnership.   
 Applications due by November 1
st
 
 Interviews by telephone in November 
 Start date December 1, 2010 
Apply online at www.CancerIowa.org  
Or email Comstock@CancerIowa.org 
If you have questions, please contact Sara Comstock at 319-335-8144. 
Information about the Iowa Cancer  
Consortium, including membership 
and programs, can be found at 
www.canceriowa.org.   Iowa Cancer Consortium 
100 MTP4 Room 162 Iowa City, IA  52242 (319) 384-1741 Toll free: 800-237-1227 
Iowan, Get Screened! 
Enhancing Community-Based Cancer Control in Iowa  
National Institutes for Health funded study 
Principal Investigator: Barcey T. Levy, PhD, MD 
 
What does my office have to do to be part of the infrastructure? 
 Participate in a learning session about cancer control issues (at a time convenient for your office—usually the 
lunch hour) 
 Communicate with grant staff or community assistants using Skype or another form of telecommunication 4-6 
times per year (at a time convenient for you) 
 Complete paperwork to conduct research at your office with the University of Iowa Institutional Review Board 
as the IRB of record to ensure the protection of human subjects 
 Obtain a Federalwide Assurance (FWA) (some of you may have it already) 
 The FWA assures that your institution engaged in research will comply with federal regulations and 
policies to conduct research 
 Have a couple of staff members certified in human subjects research (some of your staff may have 
completed this).  Human subjects training is online and takes approximately an hour to complete  
 Attend at least one state-wide meeting during the course of the 3-year grant, such as the Iowa Academy of 
Family Physicians annual meeting, the Family Physician Refresher Course, or the Iowa Cancer Summit 
 Facilitate the implementation of a computer/printer in your office for telecommunication 
Will my office be compensated?  
 The first 50 offices to agree to participate will be provided with a desktop computer and printer for use during 
future infrastructure building and studies. Each office will need to pay for appropriate internet connections and 
e-mail service. 
 Travel costs to the state-wide meetings will be covered by the grant. 
What other benefits might there be? 
 At the conclusion of the project, we will provide your office with the overall results of this infrastructure project. 
 At the conclusion of the project, your office will be ready to conduct research if you are interested in the topics 
that are funded for the Iowa Research Network or the Iowa Cancer Consortium. 
1.  Would you be interested in participating in this project to develop cancer research infrastructure through IRENE? 
      Yes       No       Unsure, would like to talk with someone.  Please call me at _____________________ 
2.  Is your practice currently a member of the Iowa Research Consortium?      Yes       No       Unsure 
3.  Does your office have a cancer disease registry?    Yes       No        Unsure 
4.  Who is the best contact person in your office _____________________________ 
5.  Phone number for this contact  ________________________ 
  ___________________________________________________________          ___________________ 
      Physician Signature           Date 
  ___________________________________________________________     
      Print Name of Office 
PLEASE FAX BACK TO Barcey T. Levy at 319-384-7647 by December 1, 2010 
Thank You! 
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UNIVERSITY of IOWA 
Recent IRENE Publications: 
1
IRENE Manuscript Submitted for Publications: 
If you are interested in receiving a copy of any of the above publications, please email the request to IRENE@uiowa.edu. 
We’re on the web!  
http://www.u iheal thcare.com/depts/med/fami lymedic ine/research/ i rene/ index .html  
University of Iowa 
Carver College of Medicine 
Department of Family Medicine 
200 Hawkins Drive, 01105 PFP 
Iowa City, IA  52242-1097 
IOWA RESEARCH NET-
Join us at the 38th Annual 
Refresher Course 
for the Family Physician 
Meet other IRENE Members and encourage  
non-IRENE physicians to join 
March 29 - April 1, 2011 
Marriott Hotel and Conference Center 
Coralville, Iowa 
IRENE Dinner: Tuesday, March 29th, 5:30 - 7:30 PM 
Coralville Marriott 
To sign up for the dinner contact: Jo Bowers, (319) 384-8994 
Email:  Josephine-bowers@uiowa.edu 
